SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    KASL clinical practice guidelines: Management of Hepatitis C, Clinical and Molecular Hepatology, 2014, 20, 2, 89

    CrossRef

  2. 2
    Susan Mathias, Ross D. Crosby, Martha S. Bayliss, Gilbert L’Italien, Sandhya Sapra, Measurement properties of the Flu-Like Symptom Index from the Hepatitis Physical Symptom Severity Diary, Quality of Life Research, 2014, 23, 5, 1489

    CrossRef

  3. 3
    M. Vera-Llonch, M. Martin, J. Aggarwal, M. Donepudi, M. Bayliss, T. Goss, Z. Younossi, Health-related quality of life in genotype 1 treatment-naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study, Alimentary Pharmacology & Therapeutics, 2013, 38, 2
  4. 4
    Naoki Harada, Naoki Hiramatsu, Tsugiko Oze, Ryoko Yamada, Mika Kurokawa, Masanori Miyazaki, Takayuki Yakushijin, Takuya Miyagi, Tomohide Tatsumi, Shinichi Kiso, Tatsuya Kanto, Akinori Kasahara, Masahide Oshita, Eiji Mita, Hideki Hagiwara, Yoshiaki Inui, Kazuhiro Katayama, Shinji Tamura, Harumasa Yoshihara, Yasuharu Imai, Atsuo Inoue, Norio Hayashi, Tetsuo Takehara, Incidence of hepatocellular carcinoma in HCV-infected patients with normal alanine aminotransferase levels categorized by Japanese treatment guidelines, Journal of Gastroenterology, 2013, 48, 4, 535

    CrossRef

  5. 5
    Necati Örmeci, Hakan Erdem, Basic answers to complicated questions for the course of chronic hepatitis C treatment, Expert Review of Gastroenterology & Hepatology, 2012, 6, 3, 371

    CrossRef

  6. 6
    Gen-Shu Wang, Yang Yang, Hua Li, Nan Jiang, Bin-Sheng Fu, Hai Jin, Jian-Xu Yang, Gui-Hua Chen, Health-related quality of life after liver transplantation: the experience from a single Chinese center, Hepatobiliary & Pancreatic Diseases International, 2012, 11, 3, 262

    CrossRef

  7. 7
    Leah Kleinman, Sally Mannix, Yong Yuan, Shannon Kummer, Gilbert L’Italien, Dennis Revicki, Review of patient-reported outcome measures in chronic hepatitis C, Health and Quality of Life Outcomes, 2012, 10, 1, 92

    CrossRef

  8. 8
    Sammy Saab, Vivian Ng, Carmen Landaverde, Sung-Jae Lee, W. Scott Comulada, Jennifer Arevalo, Francisco Durazo, Steven-Huy Han, Zobari Younossi, Ronald W. Busuttil, Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients, Liver Transplantation, 2011, 17, 5
  9. 9
    K. K. SNOW, H. L. BONKOVSKY, R. J. FONTANA, H.-Y. KIM, R. K. STERLING, A. M. DI BISCEGLIE, T. R. MORGAN, J. L. DIENSTAG, M. G. GHANY, Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C, Alimentary Pharmacology & Therapeutics, 2010, 31, 7
  10. 10
    Azucena Varela Suárez, Ricardo García Sieiro, Ana Prada Vigil, Hepatitis crónica por virus C con transaminasas normales, FMC - Formación Médica Continuada en Atención Primaria, 2010, 17, 6, 439

    CrossRef

  11. 11
    Tatsuya Ide, Michio Sata, Shotaro Sakisaka, Makoto Nakamuta, Shigetoshi Fujiyama, Toshihiko Mizuta, Kenji Tahara, Kunio Fujisaki, Yasuji Komorizono, Hiroshi Watanabe, Yasuyo Morita, Hirohito Tsubouchi, Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan, Hepatology Research, 2010, 40, 6
  12. You have free access to this content12
    Marc G. Ghany, Doris B. Strader, David L. Thomas, Leonard B. Seeff, Diagnosis, management, and treatment of hepatitis C: An update, Hepatology, 2009, 49, 4
  13. 13
    Hillary Bownik, Sammy Saab, Health-related quality of life after liver transplantation for adult recipients, Liver Transplantation, 2009, 15, S2
  14. 14
    D. T. Dieterich, M. Rizzetto, M. P. Manns, Management of chronic hepatitis C patients who have relapsed or not responded to pegylated interferon alfa plus ribavirin, Journal of Viral Hepatitis, 2009, 16, 12
  15. 15
    Debbie Hartwell, Jonathan Shepherd, Pegylated and non-pegylated interferon-alfa and ribavirin for the treatment of mild chronic hepatitis C: A systematic review and meta-analysis, International Journal of Technology Assessment in Health Care, 2009, 25, 01, 56

    CrossRef

  16. 16
    G. R. Foster, Quality of life considerations for patients with chronic hepatitis C, Journal of Viral Hepatitis, 2009, 16, 9
  17. 17
    Michiko Shindo, Treatment of chronic hepatitis C: present and future, Kanzo, 2009, 50, 7, 345

    CrossRef

  18. 18
    Catherine A. Rongey, Fasiha Kanwal, Tuyen Hoang, Allen L. Gifford, Steven M. Asch, Viral RNA Testing in Hepatitis C Antibody–Positive Veterans, American Journal of Preventive Medicine, 2009, 36, 3, 235

    CrossRef

  19. 19
    Erik J. Groessl, Kimberly R. Weingart, Robert M. Kaplan, Samuel B. Ho, Health-related quality of life in HCV-infected patients, Current Hepatitis Reports, 2007, 6, 4, 169

    CrossRef

  20. 20
    Geoffrey C Farrell, New hepatitis C guidelines for the Asia–Pacific region: APASL consensus statements on the diagnosis, management and treatment of hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2007, 22, 5
  21. 21
    Kazuo Notsumata, Manabu Tomita, Taku Sanada, Seitaro Kosaka, Daishu Toya, Nobuyosi Tanaka, Yshiko Sudo, You Zen, Usefulness of peginterferon α-2b + ribavirin combination therapy in hepatitis C virus carriers with persistently normal ALT values, Kanzo, 2007, 48, 8, 347

    CrossRef

  22. 22
    J. Crespo, Candidatos al tratamiento. Pacientes con ALT normales, Gastroenterología y Hepatología, 2006, 29, 117

    CrossRef

  23. 23
    S. ZEUZEM, A. ALBERTI, W. ROSENBERG, P. MARCELLIN, M. DIAGO, F. NEGRO, D. PRATI, C. PUOTI, S. K. ROBERTS, M. L. SHIFFMAN, Review article: management of patients with chronic hepatitis C virus infection and ‘normal’ alanine aminotransferase activity, Alimentary Pharmacology & Therapeutics, 2006, 24, 8